Genus (GENSF) Stock Price, News & Analysis

Company Overview

Genus plc is a United Kingdom-based animal genetics company that develops and supplies breeding products and related technologies for livestock producers. Its work is focused on improving the productivity, health, efficiency and sustainability of dairy, beef and pork production through advanced genetics, breeding programs and reproductive technologies.

The company operates primarily through PIC, its porcine genetics business, and ABS, which provides bovine genetics and reproduction services. PIC supplies genetic products and technical expertise to commercial pork producers, while ABS offers dairy and beef producers products such as breeding stock, bovine genetics and artificial insemination services. Genus also conducts research in areas including genomics, reproductive biology and animal health.

Genus serves agricultural customers in numerous markets worldwide, with operations and commercial activities spanning North America, Latin America, Europe, Asia and other international regions. The company’s products are distributed through direct operations, local teams and partner networks to livestock producers, breeding organizations and related agricultural businesses.

Key Stats

• Today's Range: $28.95 to $28.95
• 50-Day Range: $28.50 to $31.07
• 52-Week Range: $28.50 to $28.95
• Volume: N/A
• Average Volume: 317 shs
• Market Capitalization: N/A
• P/E Ratio: 60.81
• Dividend Yield: 0.57%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Genus Stock Analysis - MarketRank™

Genus scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Genus has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Genus has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Genus is 60.81, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.89.

Price to Earnings Ratio vs. Sector

The P/E ratio of Genus is 60.81, which means that it is trading at a more expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 44.24.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Genus has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Genus has recently decreased by 0.03%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Genus pays a meaningful dividend of 1.48%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Genus does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Genus is 34.87%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Genus insiders have not sold or bought any company stock.

Percentage Held by Institutions

29.70% of the stock of Genus is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Discretionary
• Industry: Diversified Consumer Services
• Sub-Industry: Specialized Consumer Services
• Current Symbol: OTCMKTS:GENSF
• CIK: N/A
• Web: www.genusplc.com
• Phone: 441256347100
• Fax: N/A
• Employees: 3,500
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 60.81
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A